Literature DB >> 8390097

LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.

S Davis1, T H Aldrich, N Stahl, L Pan, T Taga, T Kishimoto, N Y Ip, G D Yancopoulos.   

Abstract

The ciliary neurotrophic factor (CNTF) receptor complex is shown here to include the CNTF binding protein (CNTFR alpha) as well as the components of the leukemia inhibitory factor (LIF) receptor, LIFR beta (the LIF binding protein) and gp130 [the signal transducer of interleukin-6 (IL-6)]. Thus, the conversion of a bipartite LIF receptor into a tripartite CNTF receptor apparently occurs by the addition of the specificity-conferring element CNTFR alpha. Both CNTF and LIF trigger the association of initially separate receptor components, which in turn results in tyrosine phosphorylation of receptor subunits. Unlike the IL-6 receptor complex in which homodimerization of gp130 appears to be critical for signal initiation, signaling by the CNTF and LIF receptor complexes depends on the heterodimerization of gp130 with LIFR beta. Ligand-induced dimerization of signal-transducing receptor components, also seen with receptor tyrosine kinases, may provide a general mechanism for the transmission of a signal across the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390097     DOI: 10.1126/science.8390097

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  141 in total

1.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Involvement of diacylglycerol production in activation of nuclear factor kappaB by a CD14-mediated lipopolysaccharide stimulus.

Authors:  H Yamamoto; K Hanada; M Nishijima
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution.

Authors:  J G Zhang; C M Owczarek; L D Ward; G J Howlett; L J Fabri; B A Roberts; N A Nicola
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

4.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

5.  Ciliary neurotrophic factor improves muscle fibre reinnervation after facial nerve crush in young rats.

Authors:  H J Ulenkate; E C Kaal; W H Gispen; F G Jennekens
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.

Authors:  Takao Kuroda; Masako Tada; Hiroshi Kubota; Hironobu Kimura; Shin-ya Hatano; Hirofumi Suemori; Norio Nakatsuji; Takashi Tada
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Expression of cytokine signal transduction components in the postnatal mouse retina.

Authors:  Kun Do Rhee; Xian-Jie Yang
Journal:  Mol Vis       Date:  2003-12-16       Impact factor: 2.367

8.  Ciliary neurotrophic factor receptor regulation of adult forebrain neurogenesis.

Authors:  Nancy Lee; Myra K Batt; Brigitte A Cronier; Michele C Jackson; Jennifer L Bruno Garza; Dennis S Trinh; Carter O Mason; Rachel P Spearry; Shayon Bhattacharya; Rachel Robitz; Masato Nakafuku; A John MacLennan
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 9.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

10.  Adult ciliary neurotrophic factor receptors help maintain facial motor neuron choline acetyltransferase expression in vivo following nerve crush.

Authors:  Nancy Lee; Carolyn E Rydyznski; Matthew S Rasch; Dennis S Trinh; A John MacLennan
Journal:  J Comp Neurol       Date:  2016-11-07       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.